Real-world data analysis of immune checkpoint inhibitors in stage III-IV adenocarcinoma and squamous cell carcinoma

BACKGROUND: This study was designed to investigate the clinical application, efficacy, and safety of immune checkpoint inhibitors (ICIs) in the treatment of lung cancer in the real world. METHODS: A retrospective, observational analysis was conducted on patients treated with ICIs in four tertiary ho...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Meiling, Ji, Huaijun, Xu, Ning, Jiang, Peng, Qu, Tao, Li, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277844/
https://www.ncbi.nlm.nih.gov/pubmed/35831785
http://dx.doi.org/10.1186/s12885-022-09843-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277844/
https://www.ncbi.nlm.nih.gov/pubmed/35831785
http://dx.doi.org/10.1186/s12885-022-09843-3

Ejemplares similares